COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 154: Articles 1531-1540  | Next

SARS-CoV-2 Delta variant induces severe damages in the nasal cavity from the first day post-infection in the Syrian hamster model.
Fusade-Boyer, M., Gambino, A., Merle-Nguyen, L., Saint-Albin, A., Ando-Grard, O., Boujedli, Y., Huet, H., Ar Gouilh, M., Martin-Latil, S., Klonjkowski, B., Meunier, N., Le Poder, S.
10.1101/2024.08.30.610497 — Posted: 2024-08-30
SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7
Tian, L., Liu, Z., Gao, W., Zhao, Z., Li, X., Zhang, W., Li, Z.
10.1101/2024.08.30.610469 — Posted: 2024-08-30
Patients Experience and Satisfaction towards Virtual Health Care during the COVID-19 Pandemic in Southern Region of Saudi Arabia
Shati, A. A., Alamri, H. S., Al-Garni, A. M., Mahmood, S. E., Alsamghan, A. S. y.
10.1101/2024.08.28.24312750 — Posted: 2024-08-29
Applying Prospective Tree-Temporal Scan Statistics to Genomic Surveillance Data to Detect Emerging SARS-CoV-2 Variants and Salmonellosis Clusters in New York City
Greene, S. K., Latash, J., Peterson, E. R., Levin-Rector, A., Luoma, E., Wang, J. C., Bernard, K., Olsen, A., Li, L., Waechter, H., Mattias, A., Rohrer, R., Kulldorff, M.
10.1101/2024.08.28.24312512 — Posted: 2024-08-29
Effect of Wearing Glasses for Prevention of SARS-CoV-2 on Visits to Health Care Providers - Additional Results from a Randomized Controlled Trial
Elgersma, I. H., Elstroem, P., Hemkens, L. G., Helleve, A., Kacelnik, O., Fretheim, A.
10.1101/2024.08.29.24311868 — Posted: 2024-08-29
The effect of pre-existing coronavirus antibodies on SARS-CoV-2 infection outcomes in exposed household members
Westerhof, I., Sikkema, R. S., Rozhnova, G., Beek, J. v., Koopmans, M., Bruijning-Verhagen, P.
10.1101/2024.08.29.24312767 — Posted: 2024-08-29
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency
Joushomme, A., Desilets, A., Champagne, W., Hassanzadeh, M., Lemieux, G., Gravel-Trudeau, A., Lepage, M., Lafreniere, S., Froehlich, U., List, K., Boudreault, P.-L., Leduc, R.
10.1101/2024.08.28.609965 — Posted: 2024-08-29
FAIR assessment of MINERVA as an opportunity to foster open science and scientific crowdsourcing in systems biomedicine
Balaur, I., Welter, D., Rougny, A., Inau, E. T., Mazein, A., Ghosh, S., Schneider, R., Waltemath, D., Ostaszewski, M., Satagopam, V.
10.1101/2024.08.28.610042 — Posted: 2024-08-29
The post-viral GPNMB+ immune niche persists in long-term Covid, asthma, and COPD
Wu, K., Zhang, Y., Yin-DeClue, H., Sun, K., Mao, D., Crouch, E. C., Byers, D. E., Holtzman, M. J.
10.1101/2024.08.27.24312640 — Posted: 2024-08-28
Unsupervised detection of SARS-CoV-2 mutations and lineages in Norwegian wastewater samples using long-read sequencing
Garcia, I., Riis, R. K., Moen, L. V., Rohringer, A., Madslien, E. H., Bragstad, K.
10.1101/2024.08.27.24312690 — Posted: 2024-08-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).